University of Tennessee Research Foundation;GTx; Inc.;GTx, Inc.
发明人:
Narayanan, Ramesh,Miller, Duane D.,Ponnusamy, Thamarai,Hwang, Dong-Jin,Duke, Charles B.,Coss, Christopher C.,Jones, Amanda,Dalton, James T.
申请号：
AU2016250562
公开号：
AU2016250562A1
申请日:
2016.04.21
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
This invention provides novel 3-amino propanamide selective androgen receptor degrader (SARD) compounds, pharmaceutical compositions and uses thereof in treating prostate cancer, advanced prostate cancer, castration resistant prostate cancer, androgenic alopecia or other hyperandrogenic dermal diseases, Kennedy's disease, amyotrophic lateral sclerosis (ALS), and uterine fibroids, and to methods for reducing the levels of androgen receptor-full length (AR-FL) including pathogenic or resistance mutations, AR-splice variants (AR-SV), and pathogenic polyglutamine (polyQ) polymorphisms of AR in a subject.
